These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23527455)

  • 1. Brazilian pharmaceutical diplomacy: social democratic principles versus soft power interests.
    Flynn M
    Int J Health Serv; 2013; 43(1):67-89. PubMed ID: 23527455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global health and Brazilian foreign policy: the negotiations on innovation and intellectual property.
    Lima JHDS
    Cien Saude Colet; 2017 Jul; 22(7):2213-2221. PubMed ID: 28724003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Brazilian pharmaceutical industry and foreign trade: is there evidence of regressive specialization?].
    Mota FB; Cassiolato JE; Gadelha CA
    Cad Saude Publica; 2012 Mar; 28(3):527-36. PubMed ID: 22415185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global pharmaceutical development and access: critical issues of ethics and equity.
    Lage A
    MEDICC Rev; 2011 Jul; 13(3):16-22. PubMed ID: 21778954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intellectual property rights, the World Trade Organization and public health: the Brazilian perspective.
    Viana JM
    Conn J Int Law; 2002; 17(2):311-8. PubMed ID: 12688298
    [No Abstract]   [Full Text] [Related]  

  • 6. Tripping over trips and the global HIV/AIDS epidemic: legislation and political decisions in Brazil and the United States.
    Emilio AB
    J Contemp Health Law Policy; 2011; 28(1):57-85. PubMed ID: 22292321
    [No Abstract]   [Full Text] [Related]  

  • 7. Global health diplomacy, 'smart power', and the new world order.
    Kevany S
    Glob Public Health; 2014; 9(7):787-807. PubMed ID: 24953683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pills, patents, and power: state creation of gray markets as a limit on patent rights.
    Ghosh S
    Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioterrorism and patent rights: "compulsory licensure" and the case of Cipro.
    Resnik DB; DeVille KA
    Am J Bioeth; 2002; 2(3):29-39. PubMed ID: 12230852
    [No Abstract]   [Full Text] [Related]  

  • 10. How Brazil outpaced the United States when it came to AIDS: the politics of civic infiltration, reputation, and strategic internationalization.
    Gómez EJ
    J Health Polit Policy Law; 2011 Apr; 36(2):317-52. PubMed ID: 21543708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards.
    Cohen-Kohler JC; Forman L; Lipkus N
    Health Econ Policy Law; 2008 Jul; 3(Pt 3):229-56. PubMed ID: 18634618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Economic determinants of the demand for importation of pharmacochemical and pharmaceutical products].
    Santos AMAD; Tejada CAO; Jacinto PA
    Cad Saude Publica; 2017 Sep; 33(9):e00087916. PubMed ID: 28977272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remarks delivered at the Food and Drug Law Institute's 48th Annual Conference.
    Enzi MB
    Food Drug Law J; 2005; 60(2):103-6. PubMed ID: 16097090
    [No Abstract]   [Full Text] [Related]  

  • 14. Where does drug importation stand now?
    Guglielmo WJ
    Med Econ; 2005 Mar; 82(6):42, 44, 46. PubMed ID: 15869085
    [No Abstract]   [Full Text] [Related]  

  • 15. Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and Elsewhere.
    Baker BK
    PLoS Med; 2016 Mar; 13(3):e1001970. PubMed ID: 26954325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brazilian international cooperation in health in the era of SUS.
    Buss PM
    Cien Saude Colet; 2018 Jun; 23(6):1881-1890. PubMed ID: 29972496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to affordable HIV/AIDS drugs: the human rights obligations of multinational pharmaceutical corporations.
    Ferreira L
    Fordham Law Rev; 2002 Dec; 71(3):1133-79. PubMed ID: 12523370
    [No Abstract]   [Full Text] [Related]  

  • 18. Intellectual property rights, compulsory licensing and the TRIPS agreement: some ethical issues.
    Schuklenk U
    Monash Bioeth Rev; 2003 Apr; 22(2):63-8. PubMed ID: 15069958
    [No Abstract]   [Full Text] [Related]  

  • 19. The World Health Organization's prequalification program and its potential effect on data exclusivity laws.
    Childs DW
    Food Drug Law J; 2005; 60(1):79-97. PubMed ID: 15940855
    [No Abstract]   [Full Text] [Related]  

  • 20. Trade, TRIPS, and pharmaceuticals.
    Smith RD; Correa C; Oh C
    Lancet; 2009 Feb; 373(9664):684-91. PubMed ID: 19167054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.